REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $257 | -11.1% | 15,592 | +7.9% | 0.00% | – |
| Q2 2023 | $289 | +9.1% | 14,448 | +3.5% | 0.00% | – |
| Q1 2023 | $265 | -93.2% | 13,962 | -91.9% | 0.00% | -100.0% |
| Q4 2022 | $3,908 | -99.9% | 172,311 | -22.0% | 0.00% | 0.0% |
| Q3 2022 | $5,844,000 | +7.6% | 221,052 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $5,432,000 | -34.6% | 219,906 | -12.1% | 0.00% | 0.0% |
| Q1 2022 | $8,301,000 | -19.0% | 250,117 | -20.2% | 0.00% | 0.0% |
| Q4 2021 | $10,243,000 | -17.2% | 313,256 | +6.2% | 0.00% | 0.0% |
| Q3 2021 | $12,364,000 | +13.6% | 294,945 | +5.3% | 0.00% | 0.0% |
| Q2 2021 | $10,886,000 | +8.4% | 280,217 | -4.9% | 0.00% | 0.0% |
| Q1 2021 | $10,047,000 | -23.3% | 294,547 | +2.0% | 0.00% | 0.0% |
| Q4 2020 | $13,102,000 | +59.8% | 288,836 | -3.1% | 0.00% | 0.0% |
| Q3 2020 | $8,201,000 | -29.6% | 298,016 | -5.8% | 0.00% | 0.0% |
| Q2 2020 | $11,651,000 | +1.9% | 316,348 | -10.4% | 0.00% | -50.0% |
| Q1 2020 | $11,435,000 | -35.0% | 353,144 | -17.8% | 0.00% | 0.0% |
| Q4 2019 | $17,591,000 | -13.8% | 429,365 | -25.1% | 0.00% | -33.3% |
| Q3 2019 | $20,397,000 | -40.0% | 572,958 | -13.4% | 0.00% | -40.0% |
| Q2 2019 | $33,971,000 | -17.8% | 661,299 | -8.3% | 0.01% | -16.7% |
| Q1 2019 | $41,309,000 | +115.8% | 720,804 | +58.0% | 0.01% | +100.0% |
| Q4 2018 | $19,139,000 | -32.0% | 456,226 | +22.3% | 0.00% | -25.0% |
| Q3 2018 | $28,163,000 | +26.5% | 373,021 | +20.2% | 0.00% | +33.3% |
| Q2 2018 | $22,264,000 | +184.6% | 310,305 | +18.4% | 0.00% | +200.0% |
| Q1 2018 | $7,824,000 | -7.7% | 262,121 | +2.8% | 0.00% | 0.0% |
| Q4 2017 | $8,481,000 | +29.0% | 255,067 | -28.0% | 0.00% | 0.0% |
| Q4 2016 | $6,576,000 | -10.9% | 354,480 | -32.7% | 0.00% | 0.0% |
| Q3 2016 | $7,377,000 | -4.9% | 526,527 | -45.7% | 0.00% | -50.0% |
| Q2 2016 | $7,754,000 | -26.5% | 969,233 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $10,551,000 | -32.3% | 976,933 | +0.4% | 0.00% | -33.3% |
| Q4 2015 | $15,587,000 | -25.4% | 972,933 | -1.0% | 0.00% | -40.0% |
| Q3 2015 | $20,899,000 | – | 982,613 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |